Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059198) titled 'A Retrospective Observational Study on Treatment Outcomes Following Switching to Anti-IL-5 Therapy in EGPA' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Saitama Medical University
Condition:
Condition - eosinophilic granulomatosis with polyangiitis: EGPA
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Confirm the impact on treatment efficacy following changes in antibody therapy
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients undergoing anti-IL-5 antibody ther...